Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Abbott Richard David. Director active across 2 companies, notably Co-Diagnostics, Inc.. In total, 6 reports have been logged. Activity tracked since 23 November 2024. The latest transaction was disclosed on 23 May 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Abbott Richard David is President of Co-Diagnostics, Inc. (XNAS). He has 5 filings in total, and across the recent filings available, sales amount to EUR 4494 between 2024-11-25 and 2026-05-27, with the transaction nature shown as Attribution.